Erudio Healtherudio.com
Sponsor
Jonsson Comprehensive Cancer Center trials: what clinicians said in public
No HCP commentary report on a trial sponsored by Jonsson Comprehensive Cancer Center yet. Erudio has found public clinician commentary on 4 clinical trials sponsored by Jonsson Comprehensive Cancer Center: EXCALIBUR, LUNAR, RE-LuPSMA and SCIMITAR. Each trial's page lists the podcasts, videos and posts found so far and the price of a report.
Listed by lead sponsor as registered on ClinicalTrials.gov (Jonsson Comprehensive Cancer Center). A trial led by a partner or a research group is on that sponsor's page. Only trials with public clinician commentary found are listed, not every trial the sponsor runs.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| EXCALIBUR NCT04915508 · Jonsson Comprehensive Cancer Center DeepView → | prostate cancer with rising PSA after radical prostatectomy | Phase 2 | Deep | View | |||
| SCIMITAR NCT03541850 · Jonsson Comprehensive Cancer Center StandardView → | localized prostate cancer following radical prostatectomy | Phase 2 | Standard | View | |||
| RE-LuPSMA NCT06288113 · Jonsson Comprehensive Cancer Center FocusedView → | metastatic castration-resistant prostate cancer | Phase 2 | Focused | View | |||
| LUNAR NCT05496959 · Jonsson Comprehensive Cancer Center FocusedView → | oligorecurrent prostate cancer | Phase 2 | Focused | View | |||